危険なタンパク質にブレーキをかける(Pumping the brakes on dangerous proteins)

ad

2024-11-08 ノースウェスタン大学

ノースウェスタン大学とブロード研究所の研究者は、CHD2遺伝子の隣接領域に位置する長鎖非コードRNA「CHASERR」が、CHD2タンパク質の産生を抑制する役割を持つことを発見しました。CHASERRの欠失によりCHD2タンパク質が過剰に生成され、患者は歩行困難、言語障害、知的障害などの重度の神経発達障害を呈します。この発見は、てんかんや自閉症などの遺伝性疾患の新たな治療法開発に繋がる可能性があり、また、未解明の非コード領域の研究の重要性を示しています。

<関連情報>

神経発達障害はlncRNA遺伝子CHASERRの欠失によって引き起こされる Neurodevelopmental Disorder Caused by Deletion of CHASERR, a lncRNA Gene

Vijay S. Ganesh, M.D., Ph.D., Kevin Riquin, Ph.D., Nicolas Chatron, M.D., Ph.D., Esther Yoon, B.S., Kay-Marie Lamar, Ph.D., Miriam C. Aziz, B.S., Pauline Monin, M.D., +23, and Anne O’Donnell-Luria, M.D., Ph.D.
New England Journal of Medicine  Published: October 23, 2024
DOI:10.1056/NEJMoa2400718

Summary

CHASERR encodes a human long noncoding RNA (lncRNA) adjacent to CHD2, a coding gene in which de novo loss-of-function variants cause developmental and epileptic encephalopathy. Here, we report our findings in three unrelated children with a syndromic, early-onset neurodevelopmental disorder, each of whom had a de novo deletion in the CHASERR locus. The children had severe encephalopathy, shared facial dysmorphisms, cortical atrophy, and cerebral hypomyelination — a phenotype that is distinct from the phenotypes of patients with CHD2 haploinsufficiency. We found that the CHASERR deletion results in increased CHD2 protein abundance in patient-derived cell lines and increased expression of the CHD2 transcript in cis. These findings indicate that CHD2 has bidirectional dosage sensitivity in human disease, and we recommend that other lncRNA-encoding genes be evaluated, particularly those upstream of genes associated with mendelian disorders. (Funded by the National Human Genome Research Institute and others.)

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました